Washington Targetting Drugmakers?

NEW YORK/WASHINGTON — The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers. The abandoned proposal would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to …

Blue Choice Copay Card change announced

Specialty Drug Copay Card Program Many drug manufacturers offer copay cards to commercially insured consumers, which reduce the member’s personal out-of-pocket expense for the drug while frequently driving utilization to high-cost, branded specialty drugs. These cards are made available to all members, unlike needs-based cards that are used only by members with documented financial hardship. Previously, third-party dollars available through …